Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice

被引:186
作者
Takeda, H
Tsuji, M
Inazu, M
Egashira, T
Matsumiya, T
机构
[1] Tokyo Med Univ, Div Drug Res & Dev, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan
[2] Tokyo Med Univ, Div Drug Res & Dev, Intractable Dis Res Ctr, Shinjuku Ku, Tokyo 1608402, Japan
[3] Oita Med Univ, Dept Pharmacol, Oita 87985593, Japan
关键词
rosmarinic acid; caffeic acid; forced swimming test; antidepressant; (mouse);
D O I
10.1016/S0014-2999(02)02037-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously showed that rosmarinic acid from the leaves of Perilla frutescens Britton var. acuta Kudo (Perillae Herba) has antidepressive-like activity. The aim of the present study was to examine (i) whether caffeic acid, a major metabolite of rosmarinic acid, also has antidepressive-like activity, and (ii) whether these substances inhibit either the uptake of monoamines to synaptosomes or mitochondrial monoamine oxidase activity. Rosmarinic acid (2 mg/kg, i.p.) and caffeic acid (4 mg/kg, i.p.) each significantly reduced the duration of immobility in the forced swimming test in mice. In contrast, neither substance, at doses that produced a significant reduction in the immobile response in the forced swimming test, affected spontaneous motor activity. These results indicate that, like rosmarinic acid, caffeic acid also possesses antidepressive-like activity. In neuropharmacological studies, neither rosmarinic acid (10(-9)-10(-3) M) nor caffeic acid (10(-9)-10(-3) M) affected either the uptake of monoamines to synaptosomes or mitochondrial monoamine oxidase activity in the mouse brain. These results suggest that both caffeic acid and rosmarinic acid may produce antidepressive-like activity via some mechanism(s) other than the inhibition of monoamine transporters and monoamine oxidase. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 38 条
[1]  
BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483
[2]   Stimulatory effect of caffeic acid on α1A-adrenoceptors to increase glucose uptake into cultured C2C12 cells [J].
Cheng, JT ;
Liu, IM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (02) :122-127
[3]   Depressive illness [J].
Doris, A ;
Ebmeier, K ;
Shajahan, P .
LANCET, 1999, 354 (9187) :1369-1375
[4]   The inhibition of monoamine oxidase activity by various antidepressants: Differences found in various mammalian species [J].
Egashira, T ;
Takayama, F ;
Yamanaka, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1999, 81 (01) :115-121
[5]   CHANGES IN MONOAMINE-OXIDASE ACTIVITY IN MOUSE-BRAIN ASSOCIATED WITH D-METHAMPHETAMINE DEPENDENCE AND WITHDRAWAL [J].
EGASHIRA, T ;
YAMANAKA, Y .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (04) :609-614
[6]   Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain [J].
Egashira, T ;
Takayama, F ;
Yamanaka, Y .
GENERAL PHARMACOLOGY, 1996, 27 (05) :773-778
[7]  
Fukushima M, 1997, Seishin Shinkeigaku Zasshi, V99, P355
[8]  
Gumnick JF, 2000, J CLIN PSYCHIAT, V61, P5
[9]   Nitric oxide synthase inhibitors have antidepressant-like properties in mice 1. Acute treatments are active in the forced swim test [J].
Harkin, AJ ;
Bruce, KH ;
Craft, B ;
Paul, IA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (03) :207-213
[10]   Pharmacological characterization and visualization of the glial serotonin transporter [J].
Inazu, M ;
Takeda, H ;
Ikoshi, H ;
Sugiswa, M ;
Uchida, Y ;
Matsumiya, T .
NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (01) :39-49